Julia M W Gee Selected Research

Neoplasms (Cancer)

1/2024	The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer.
4/2022	The importance of targeting signalling mechanisms of the SLC39A family of zinc transporters to inhibit endocrine resistant breast cancer.
1/2020	Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT).
1/2019	MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer.
1/2016	Biological effects of fulvestrant on estrogen receptor positive human breast cancer: short, medium and long-term effects based on sequential biopsies.
1/2016	Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer.
12/2015	ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells.
7/2015	DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer.
12/2014	A good drug made better: the fulvestrant dose-response story.
11/2013	Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julia M W Gee Research Topics

Disease

38	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2003
24	Neoplasms (Cancer) 01/2024 - 01/2003
4	Neoplasm Metastasis (Metastasis) 01/2016 - 12/2006
2	Disease Progression 12/2015 - 01/2004
1	Inflammation (Inflammations) 12/2015

Drug/Important Bio-Agent (IBA)

17	Tamoxifen FDA LinkGeneric 04/2022 - 01/2003
8	Estrogen ReceptorsIBA 01/2024 - 01/2003
7	Biomarkers (Surrogate Marker)IBA 12/2022 - 09/2013
7	ErbB Receptors (EGF Receptor)IBA 09/2011 - 01/2003
6	Hormones (Hormone)IBA 01/2019 - 01/2003
6	Fulvestrant (Faslodex)FDA Link 01/2016 - 09/2003
6	Phenobarbital (Luminal)FDA Link 12/2015 - 12/2008
5	Estrogens (Estrogen)FDA Link 12/2015 - 01/2012
5	Estrogen Receptor Modulators (Antiestrogen)IBA 12/2015 - 01/2003
5	Proteins (Proteins, Gene)FDA Link 11/2013 - 03/2004
4	Gefitinib (Iressa)FDA Link 01/2018 - 01/2003
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2011 - 01/2003
3	ChromatinIBA 01/2024 - 01/2012
3	Tyrosine (L-Tyrosine)FDA Link 11/2013 - 09/2008
2	capivasertibIBA 12/2022 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2019 - 03/2004
2	Neuregulin-1 (Neuregulin 1)IBA 01/2018 - 03/2011
2	DNA (Deoxyribonucleic Acid)IBA 07/2015 - 01/2012
2	Phosphotransferases (Kinase)IBA 01/2014 - 03/2011
2	Progesterone Receptors (Progesterone Receptor)IBA 03/2013 - 05/2012
2	Somatomedin Receptors (Somatomedin Receptor)IBA 09/2011 - 03/2004
2	Tyrosine Kinase InhibitorsIBA 12/2006 - 01/2003
2	SteroidsIBA 09/2004 - 01/2003
1	Decitabine FDA Link 01/2024
1	ZincIBA 04/2022
1	MicroRNAs (MicroRNA)IBA 01/2019
1	zinc-binding protein (zinc binding protein)IBA 01/2019
1	Long Noncoding RNAIBA 01/2016
1	AntibodiesIBA 12/2015
1	Tumor Biomarkers (Tumor Markers)IBA 12/2014
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2014
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 01/2014
1	Antimitotic AgentsIBA 09/2013
1	Cytotoxins (Cytolysins)IBA 09/2013
1	Anastrozole (Arimidex)FDA LinkGeneric 03/2013
1	ClaudinsIBA 01/2012
1	Proto-Oncogene Proteins c-etsIBA 01/2012
1	Insulin Receptor Substrate ProteinsIBA 09/2011
1	Insulin-Like PeptidesIBA 09/2011
1	Transferrin (beta 2 Transferrin)IBA 01/2010
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2010
1	Steroid Receptors (Steroid Receptor)IBA 01/2010
1	Insulin ReceptorIBA 12/2008
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2008
1	AgarIBA 12/2008
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 12/2008
1	BMS 536924IBA 12/2008
1	Eicosapentaenoic AcidIBA 11/2008
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 11/2008
1	Fish OilsIBA 11/2008
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 11/2008
1	histidine-rich proteinsIBA 01/2007
1	heregulin beta1IBA 01/2007
1	Growth Factor ReceptorsIBA 12/2006
1	ParaffinIBA 03/2004
1	RNA (Ribonucleic Acid)IBA 03/2004
1	Messenger RNA (mRNA)IBA 03/2004
1	Complement System Proteins (Complement)IBA 03/2004

Therapy/Procedure

16	Therapeutics 01/2024 - 12/2006
2	Drug Therapy (Chemotherapy) 12/2014 - 09/2013